Fizazi K - Search Results

1

Clinical progression is associated with poor prognosis whatever the treatment line in metastatic castration resistant prostate cancer: The CATS international database.

Delanoy N, Hardy-Bessard AC, Efstathiou E, Le Moulec S, Basso U, Birtle A, Thomson A, Krainer M, Guillot A, De Giorgi U, Hasbini A, Daugaard G, Bahl A, Chowdhury S, Caffo O, Beuzeboc P, Spaeth D, Eymard JC, Fléchon A, Alexandre J, Helissey C, Butt M, Priou F, Lechevallier E, Deville JL, Gross-Goupil M, Morales R, Thiery-Vuillemin A, Gavrikova T, Barthélémy P, Sella A, Fizazi K, Ferrero JM, Laguerre B, Thibault C, Hans S, Oudard S. Delanoy N, et al. Among authors: fizazi k. Eur J Cancer. 2020 Jan;125:153-163. doi: 10.1016/j.ejca.2019.10.030. Epub 2019 Nov 29. Eur J Cancer. 2020. PMID: 31787484

2

Meningeal carcinomatosis in patients with breast carcinoma. Clinical features, prognostic factors, and results of a high-dose intrathecal methotrexate regimen.

Fizazi K, Asselain B, Vincent-Salomon A, Jouve M, Dieras V, Palangie T, Beuzeboc P, Dorval T, Pouillart P. Fizazi K, et al. Cancer. 1996 Apr 1;77(7):1315-23. doi: 10.1002/(SICI)1097-0142(19960401)77:7<1315::AID-CNCR14>3.0.CO;2-4. Cancer. 1996. PMID: 8608509 Clinical Trial.

3

Normal serum neuron specific enolase (NSE) value after the first cycle of chemotherapy: an early predictor of complete response and survival in patients with small cell lung carcinoma.

Fizazi K, Cojean I, Pignon JP, Rixe O, Gatineau M, Hadef S, Arriagada R, Baldeyrou P, Comoy E, Le Chevalier T. Fizazi K, et al. Cancer. 1998 Mar 15;82(6):1049-55. doi: 10.1002/(sici)1097-0142(19980315)82:6<1049::aid-cncr6>3.0.co;2-9. Cancer. 1998. PMID: 9506348

4

Initial management of primary mediastinal seminoma: radiotherapy or cisplatin-based chemotherapy?

Fizazi K, Culine S, Droz JP, Terrier-Lacombe MJ, Théodore C, Wibault P, Rixe O, Ruffié P, Le Chevalier T. Fizazi K, et al. Eur J Cancer. 1998 Feb;34(3):347-52. doi: 10.1016/s0959-8049(97)10021-1. Eur J Cancer. 1998. PMID: 9640220 Review.

5

The growing teratoma syndrome: results of therapy and long-term follow-up of 33 patients.

André F, Fizazi K, Culine S, Droz J, Taupin P, Lhommé C, Terrier-Lacombe M, Théodore C. André F, et al. Among authors: fizazi k. Eur J Cancer. 2000 Jul;36(11):1389-94. doi: 10.1016/s0959-8049(00)00137-4. Eur J Cancer. 2000. PMID: 10899652

6

Peritoneal carcinomatosis in germ-cell tumor: relations with retroperitoneal lymph node dissection.

Andre F, Fizazi K, Culine S, Droz JP, Gatineau M, Takahashi Y, Oudard S, Theodore C. Andre F, et al. Among authors: fizazi k. Am J Clin Oncol. 2000 Oct;23(5):460-2. doi: 10.1097/00000421-200010000-00006. Am J Clin Oncol. 2000. PMID: 11039504

7

Stage I non-seminomatous germ-cell tumours of the testis: identification of a subgroup of patients with a very low risk of relapse.

Alexandre J, Fizazi K, Mahé C, Culine S, Droz JP, Théodore C, Terrier-Lacombe MJ. Alexandre J, et al. Among authors: fizazi k. Eur J Cancer. 2001 Mar;37(5):576-82. doi: 10.1016/s0959-8049(00)00442-1. Eur J Cancer. 2001. PMID: 11290432

8

Viable malignant cells after primary chemotherapy for disseminated nonseminomatous germ cell tumors: prognostic factors and role of postsurgery chemotherapy--results from an international study group.

Fizazi K, Tjulandin S, Salvioni R, Germà-Lluch JR, Bouzy J, Ragan D, Bokemeyer C, Gerl A, Fléchon A, de Bono JS, Stenning S, Horwich A, Pont J, Albers P, De Giorgi U, Bower M, Bulanov A, Pizzocaro G, Aparicio J, Nichols CR, Théodore C, Hartmann JT, Schmoll HJ, Kaye SB, Culine S, Droz JP, Mahé C. Fizazi K, et al. J Clin Oncol. 2001 May 15;19(10):2647-57. doi: 10.1200/JCO.2001.19.10.2647. J Clin Oncol. 2001. PMID: 11352956

9

Germ cell tumors in patients infected by the human immunodeficiency virus.

Fizazi K, Amato RJ, Beuzeboc P, Petit N, Bouhour D, Thiss A, Rebischung C, Chevreau C, Logothetis CJ, Droz JP. Fizazi K, et al. Cancer. 2001 Sep 15;92(6):1460-7. doi: 10.1002/1097-0142(20010915)92:6<1460::aid-cncr1470>3.0.co;2-i. Cancer. 2001. PMID: 11745223

10

Weekly vinorelbine is an effective palliative regimen after failure with anthracyclines and taxanes in metastatic breast carcinoma.

Zelek L, Barthier S, Riofrio M, Fizazi K, Rixe O, Delord JP, Le Cesne A, Spielmann M. Zelek L, et al. Among authors: fizazi k. Cancer. 2001 Nov 1;92(9):2267-72. doi: 10.1002/1097-0142(20011101)92:9<2267::aid-cncr1572>3.0.co;2-q. Cancer. 2001. PMID: 11745280 Clinical Trial.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

521 results

Search Page